Evidence map›Paper›PMID 23979754›Full record

ArticleAntimicrobial agents and chemotherapy2013

Superoxide-mediated protection of Escherichia coli from antimicrobials.

Michael Mosel, Liping Li, Karl Drlica, Xilin Zhao

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The HCurrent research in microbial sciences · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Sublethal Paraquat Confers Multidrug Tolerance inFrontiers in microbiology · 2020
    Article
  14. Article
  15. Post-stress bacterial cell death mediated by reactive oxygen species.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Review
  17. Antibiotic efficacy-context matters.Current opinion in microbiology · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Michael MoselPublic Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
Liping Li
Karl Drlica
Xilin Zhao
Rutgers HealthRutgers, The State University of New Jersey · US

Funding

Novel fluoroquinolones for killing dormant Mycobacterium tuberculosisR01AI073491 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DRLICA, KARL A, KERNS, ROBERT JOHN · 2007 to 2015
$5.1M
Anaerobic shock as a novel treatment for tuberculosisDP2OD007423 · OD · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ZHAO, XILIN · 2010 to 2010
$2.3M
NIAID NIH HHS 1-R01-AI 073491NIAID NIH HHS R01 AI073491NIH HHS 1-DP2-OD007423NIH HHS DP2 OD007423
6 · The paper itself

Abstract

Antimicrobial lethality is promoted by reactive oxygen species (ROS), such as superoxide, peroxide, and hydroxyl radical. Pretreatment with subinhibitory concentrations of plumbagin or paraquat, metabolic generators of superoxide, paradoxically reduced killing for oxolinic acid, kanamycin, and ampicillin. These pretreatments also reduced an oxolinic acid-mediated ROS surge. Defects in SoxS MarA or AcrB eliminated plumbagin- and paraquat-mediated MIC increases but maintained protection from killing. Thus, superoxide has both protective and detrimental roles in response to antimicrobial stress.

Indexed as

Gene Expression Regulation, BacterialAmpicillinAnti-Bacterial AgentsATP-Binding Cassette, Sub-Family C ProteinsDNA-Binding ProteinsDose-Response Relationship, DrugDrug Resistance, BacterialEscherichia coli K12Escherichia coli ProteinsKanamycinMicrobial Sensitivity TestsNaphthoquinonesOxolinic AcidParaquatSuperoxidesTrans-ActivatorsAcrB protein, E coliAmpicillinAnti-Bacterial AgentsATP-Binding Cassette, Sub-Family C ProteinsDNA-Binding ProteinsEscherichia coli ProteinsKanamycinMarA protein, E coliNaphthoquinonesOxolinic AcidParaquatplumbaginSoxS protein, E coliSuperoxidesTrans-Activators

Identifiers

PMID23979754
PMCPMC3811261
OpenAlexW2132811469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.